|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Essential hypertension | 2022-12-16 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| 72 HR Fentanyl 0.025 MG/HR Transdermal System | 2024-12-27 | 0.025 mg per hour, apply every 72 hours | ||
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2024-12-27 | Oral tablet | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Acetaminophen 300 mg and codeine phosphate 15 mg oral tablet | 2024-12-27 | Oral tablet | 1 tablet (300 mg/15 mg) every 4 to 6 hours as needed | |
| Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin] | 2024-12-27 | 1 tablet (10 mg) every 12 hours | ||
| Acetaminophen 325 MG / Oxycodone Hydrochloride 10 MG Oral Tablet [Percocet] | 2024-12-27 | 1 tablet (325 mg / 10 mg) every 6 hours as needed | ||
| 12 HR Hydrocodone Bitartrate 10 MG Extended Release Oral Capsule | 2024-12-27 | 1 capsule (10 mg) every 12 hours |
Allergies and Intolerances
| No known allergies or intolerances |
Immunizations list
| Vaccine | Date |
|---|---|
| Hepatitis B virus antigen only vaccine product | 2024-12-27 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 2024-12-27 |
| Neisseria meningitidis antigen-containing vaccine product | 2024-12-27 |
| Influenza virus antigen only vaccine product | 2024-12-27 |
| Human papillomavirus 6 | 2016-11-11 |
Care Plan
| Active Planned Care | Date | Reason |
|---|---|---|
| Routine antenatal care | 2023-05-12 | - |
| Lifestyle education regarding hypertension | 2022-12-16 | Essential hypertension (disorder) |
| Therapy | 2022-01-28 | - |
| Weight management program | 2017-11-17 | - |
History of Past Illness
| Condition | Period | Status |
|---|---|---|
| Anemia | 2023-05-12 – 2023-07-22 | inactive |
| Concussion with no loss of consciousness | 2020-07-04 – 2020-09-11 | inactive |
| Concussion injury of brain | 2020-07-04 – 2020-09-11 | inactive |
Vital Signs
| Vital Signs | 2024-12-27 | 2023-12-22 |
|---|---|---|
| Body Height | 164 cm | 164 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 1 {score} | 3 {score} |
| Body Weight | 84.2 kg | 84.2 kg |
| Body mass index (BMI) [Ratio] | 31.3 kg/m2 | 31.3 kg/m2 |
| Diastolic Blood Pressure | 86 mm[Hg] | 84 mm[Hg] |
| Systolic Blood Pressure | 130 mm[Hg] | 123 mm[Hg] |
| Heart rate | 88 /min | 63 /min |
| Respiratory rate | 16 /min | 14 /min |